CERE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $147,510,898.72

Insider Selling (Last 12 Months): $21,054,440.60

Cerevel Therapeutics Insider Trading History Chart

Cerevel Therapeutics Share Price & Price History

^$42.14

▲ +0.24 (0.57%)

As of 04/25/2024 03:39 PM ET

Days: 30 | 90 | 365

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

Cerevel Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/4/2024	Anthony Coles	Director	Sell	50,000	$41.01	$2,050,500.00	15,638
2/29/2024	Anthony Coles	Director	Sell	50,000	$41.16	$2,058,000.00	15,638
2/7/2024	John Renger	Insider	Sell	2,161	$41.54	$89,767.94	6,370
2/7/2024	Anthony Coles	Director	Sell	2,506	$41.54	$104,099.24	15,638
12/26/2023	Ramiro Sanchez	Insider	Sell	10,000	$42.47	$424,700.00	14,673
12/22/2023	Kenneth DiPietro	Insider	Sell	8,000	$41.45	$331,600.00	24,663
12/20/2023	Mark Bodenrader	Insider	Sell	7,889	$41.42	$326,762.38	17,724
12/20/2023	Susan Altschuller	CFO	Sell	13,808	$41.42	$571,927.36	16,913
12/7/2023	Scott Akamine	Insider	Sell	10,000	$41.37	$413,700.00	513
12/5/2023	Scott Akamine	Insider	Sell	7,500	$35.00	$262,500.00	513
11/8/2023	Anthony Coles	Director	Sell	100	$25.16	$2,516.00	2,704
11/3/2023	Anthony Coles	Director	Sell	61,401	$25.43	$1,561,427.43	2,704
10/16/2023	Bain Capital Investors Llc	Major Shareholder	Buy	5,480,052	$22.81	$124,999,986.12	65,679,781
10/16/2023	Perceptive Advisors Llc	Director	Buy	876,808	$22.81	$19,999,990.48	10,794,876
9/7/2023	Anthony Coles	Director	Sell	50,000	$24.07	$1,203,500.00	2,704
8/4/2023	Paul D. Burgess	Insider	Buy	21,880	$22.93	$501,708.40	21,880
8/3/2023	Ronald C. Renaud, Jr.	CEO	Buy	83,857	$23.96	$2,009,213.72	83,857
7/11/2023	Anthony Coles	Director	Sell	50,000	$30.03	$1,501,500.00	2,704
6/15/2023	Marijn E Dekkers	Director	Sell	200,000	$34.43	$6,886,000.00	402,326
6/2/2023	Mark Bodenrader	Insider	Sell	1,895	$32.95	$62,440.25	5,522
6/1/2023	Anthony Coles	CEO	Sell	50,000	$32.60	$1,630,000.00	2,704
5/4/2023	Anthony Coles	CEO	Sell	50,000	$31.47	$1,573,500.00	2,704
4/11/2023	Anthony Coles	CEO	Sell	50,000	$25.06	$1,253,000.00	2,704
3/3/2023	Anthony Coles	CEO	Sell	3,000	$27.19	$81,570.00	2,704
2/7/2023	Anthony Coles	CEO	Sell	50,000	$33.13	$1,656,500.00	2,704
1/5/2023	Anthony Coles	CEO	Sell	50,000	$29.94	$1,497,000.00	2,704
12/9/2022	Anthony Coles	CEO	Sell	50,000	$26.67	$1,333,500.00	2,704
10/4/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
9/12/2022	Deval L. Patrick	Director	Sell	47,705	$30.78	$1,468,359.90
9/8/2022	Abraham Ceesay	President	Sell	19,210	$32.50	$624,325.00
8/22/2022	Abraham Ceesay	President	Sell	9,605	$32.50	$312,162.50
8/16/2022	Perceptive Advisors Llc	Director	Buy	1,425,000	$35.00	$49,875,000.00	6,511,727
8/10/2022	John Renger	Insider	Sell	55,000	$40.50	$2,227,500.00	2,704
7/20/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
7/5/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
4/13/2022	John Renger	Insider	Sell	45,000	$34.65	$1,559,250.00	1,980
3/29/2022	John Renger	Insider	Sell	10,000	$35.00	$350,000.00
3/18/2022	John Renger	Insider	Sell	20,000	$32.50	$650,000.00
3/16/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
2/9/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
12/27/2021	John Renger	Insider	Sell	4,127	$35.00	$144,445.00
12/23/2021	John Renger	Insider	Sell	5,873	$35.00	$205,555.00
12/21/2021	John Renger	Insider	Sell	7,300	$32.50	$237,250.00
12/17/2021	John Renger	Insider	Sell	7,122	$32.50	$231,465.00
12/15/2021	John Renger	Insider	Sell	25,000	$30.02	$750,500.00
11/10/2021	John Renger	Insider	Sell	55,000	$39.86	$2,192,300.00
8/25/2021	Perceptive Advisors Llc	Director	Buy	61,387	$28.57	$1,753,826.59
8/23/2021	Perceptive Advisors Llc	Director	Buy	44,437	$25.78	$1,145,585.86
7/7/2021	Perceptive Advisors Llc	Director	Buy	200,000	$25.00	$5,000,000.00
6/17/2021	Gabrielle Sulzberger	Director	Buy	21,084	$13.06	$275,357.04	35,354

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

87.73% of Cerevel Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cerevel Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/29/2024	Kapitalo Investimentos Ltda	180,000	$7.63M	1.6%	N/A	0.099%
3/22/2024	PNC Financial Services Group Inc.	6,500	$0.28M	0.0%	-31.6%	0.004%
3/11/2024	Vanguard Group Inc.	7,374,970	$312.70M	0.0%	+15.8%	4.062%
3/5/2024	Wellington Management Group LLP	35,578	$1.51M	0.0%	-25.5%	0.020%
3/1/2024	Goldman Sachs Group Inc.	532,757	$22.59M	0.0%	+64.2%	0.294%
2/26/2024	Centaurus Financial Inc.	2,800	$0.12M	0.0%	N/A	0.002%
2/26/2024	Virtu Financial LLC	5,803	$0.25M	0.0%	N/A	0.003%
2/26/2024	Perceptive Advisors LLC	10,965,193	$464.92M	10.4%	+8.7%	6.044%
2/15/2024	Governors Lane LP	364,400	$15.45M	1.6%	N/A	0.202%
2/14/2024	Twin Securities Inc.	232,705	$9.87M	10.4%	N/A	0.129%
2/14/2024	Avidity Partners Management LP	276,888	$11.74M	0.4%	-56.9%	0.154%
2/14/2024	PenderFund Capital Management Ltd.	9,400	$0.40M	0.0%	N/A	0.005%
2/14/2024	Avoro Capital Advisors LLC	7,555,555	$320.36M	4.4%	+690.7%	4.191%
2/14/2024	Water Island Capital LLC	588,100	$24.94M	2.6%	N/A	0.326%
2/13/2024	Bain Capital Investors LLC	65,679,781	$2.78B	60.4%	+9.1%	36.432%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	275,500	$11.68M	2.2%	N/A	0.153%
2/13/2024	Gabelli Funds LLC	465,621	$19.74M	0.2%	N/A	0.258%
2/13/2024	Capital International Investors	863,786	$36.63M	0.0%	N/A	0.479%
2/13/2024	Lake Street Advisors Group LLC	244,309	$10.36M	0.7%	+191.3%	0.136%
2/13/2024	Affinity Asset Advisors LLC	750,000	$31.80M	5.9%	+9.5%	0.416%
2/13/2024	Carmignac Gestion	44,181	$1.87M	0.0%	N/A	0.025%
2/13/2024	Rafferty Asset Management LLC	141,477	$6M	0.0%	-28.9%	0.078%
2/12/2024	Olympiad Research LP	47,304	$2.01M	1.6%	N/A	0.026%
2/12/2024	Allianz Asset Management GmbH	144,400	$6.12M	0.0%	N/A	0.080%
2/12/2024	Hsbc Holdings PLC	408,032	$17.32M	0.0%	N/A	0.226%
2/9/2024	Westfield Capital Management Co. LP	785,494	$33.31M	0.2%	-19.4%	0.436%
2/9/2024	Aigen Investment Management LP	8,215	$0.35M	0.1%	N/A	0.005%
2/9/2024	PNC Financial Services Group Inc.	6,500	$0.28M	0.0%	-31.6%	0.004%
2/9/2024	Norges Bank	685,694	$29.07M	0.0%	N/A	0.380%
2/7/2024	Principal Financial Group Inc.	27,117	$1.15M	0.0%	+1.6%	0.015%
2/7/2024	Teacher Retirement System of Texas	16,032	$0.68M	0.0%	-10.0%	0.009%
2/7/2024	Versor Investments LP	108,657	$4.61M	0.9%	N/A	0.060%
2/7/2024	Alpine Associates Management Inc.	1,644,100	$69.71M	3.6%	N/A	0.912%
2/7/2024	Kellner Capital LLC	20,300	$0.86M	1.6%	N/A	0.011%
2/7/2024	E Fund Management Co. Ltd.	7,599	$0.32M	0.0%	-25.7%	0.004%
2/7/2024	Segantii Capital Management Ltd	594,519	$25.21M	1.3%	N/A	0.330%
2/6/2024	Pacific Capital Wealth Advisors Inc.	1,672	$71K	0.0%	N/A	0.001%
2/6/2024	Charles Schwab Investment Management Inc.	649,333	$27.53M	0.0%	+25.5%	0.360%
2/6/2024	BCK Capital Management LP	22,000	$0.93M	0.9%	N/A	0.012%
2/6/2024	Amalgamated Bank	10,027	$0.43M	0.0%	+8.8%	0.006%
2/6/2024	Swiss National Bank	139,700	$5.92M	0.0%	+1.3%	0.077%
2/5/2024	Victory Capital Management Inc.	11,592	$0.49M	0.0%	N/A	0.006%
2/1/2024	New York State Common Retirement Fund	28,535	$1.21M	0.0%	+5.1%	0.016%
2/1/2024	Handelsbanken Fonder AB	16,200	$0.69M	0.0%	+39.7%	0.009%
1/31/2024	Calamos Advisors LLC	305,303	$12.95M	0.1%	N/A	0.169%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	13,170	$0.56M	0.0%	+9.0%	0.007%
1/30/2024	Strs Ohio	9,800	$0.42M	0.0%	-3.9%	0.005%
1/25/2024	International Assets Investment Management LLC	55,120	$23.37M	0.1%	N/A	0.031%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	36,363	$1.54M	0.0%	+6.2%	0.020%
1/24/2024	International Assets Investment Management LLC	55,120	$23.37M	0.0%	N/A	0.031%
1/24/2024	Arizona State Retirement System	19,816	$0.84M	0.0%	+10.9%	0.011%
1/23/2024	GAM Holding AG	5,000	$0.21M	0.0%	N/A	0.003%
1/17/2024	Assenagon Asset Management S.A.	299,891	$12.72M	0.0%	N/A	0.166%
1/12/2024	FNY Investment Advisers LLC	8,000	$0.34M	0.4%	N/A	0.004%
1/12/2024	SG Americas Securities LLC	24,487	$1.04M	0.0%	N/A	0.014%
12/18/2023	Vanguard Group Inc.	6,371,376	$139.09M	0.0%	+12.5%	3.534%
12/7/2023	Hudson Bay Capital Management LP	50,000	$1.09M	0.0%	N/A	0.028%
12/1/2023	Wellington Management Group LLP	47,760	$1.04M	0.0%	N/A	0.026%
11/30/2023	American Century Companies Inc.	307,743	$6.72M	0.0%	-0.5%	0.171%
11/22/2023	Polar Capital Holdings Plc	10,762	$0.24M	0.0%	-98.8%	0.006%
11/22/2023	Graham Capital Management L.P.	41,850	$0.91M	0.0%	+304.6%	0.023%
11/15/2023	Rock Springs Capital Management LP	2,529,116	$55.21M	1.5%	+0.6%	1.403%
11/15/2023	Lake Street Advisors Group LLC	83,857	$1.83M	0.1%	N/A	0.047%
11/15/2023	Adage Capital Partners GP L.L.C.	1,505,976	$32.88M	0.1%	+100.8%	0.835%
11/15/2023	Alps Advisors Inc.	116,263	$2.54M	0.0%	+0.9%	0.064%
11/15/2023	Affinity Asset Advisors LLC	685,061	$14.96M	4.2%	+24.6%	0.380%
11/14/2023	Avidity Partners Management LP	643,000	$14.04M	0.6%	+28.3%	0.357%
11/14/2023	Trexquant Investment LP	14,397	$0.31M	0.0%	N/A	0.008%
11/14/2023	Westfield Capital Management Co. LP	974,483	$21.27M	0.1%	+69.3%	0.541%
11/14/2023	Profund Advisors LLC	33,984	$0.74M	0.0%	+4.2%	0.019%
11/13/2023	Dark Forest Capital Management LP	12,247	$0.27M	0.0%	N/A	0.007%
11/13/2023	FMR LLC	23,623,144	$515.69M	0.0%	+0.6%	13.104%
11/13/2023	Rafferty Asset Management LLC	198,993	$4.34M	0.0%	+12.6%	0.110%
11/13/2023	PNC Financial Services Group Inc.	9,506	$0.21M	0.0%	+68.5%	0.005%
11/13/2023	E Fund Management Co. Ltd.	10,223	$0.22M	0.0%	+7.6%	0.006%
11/9/2023	Rhumbline Advisers	87,671	$1.91M	0.0%	-0.7%	0.056%
11/9/2023	Deutsche Bank AG	33,927	$0.74M	0.0%	+15.7%	0.022%
11/9/2023	Citigroup Inc.	83,786	$1.83M	0.0%	+22.7%	0.053%
11/8/2023	Charles Schwab Investment Management Inc.	517,244	$11.29M	0.0%	+3.0%	0.328%
11/8/2023	Swiss National Bank	137,900	$3.01M	0.0%	+1.1%	0.088%
11/7/2023	Barclays PLC	145,910	$3.19M	0.0%	+11.1%	0.093%
10/31/2023	Teacher Retirement System of Texas	17,818	$0.39M	0.0%	+4.8%	0.011%
10/27/2023	TD Asset Management Inc	372,146	$8.12M	0.0%	+82.9%	0.236%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	12,079	$0.26M	0.0%	+19.0%	0.008%
10/24/2023	Bank of New York Mellon Corp	263,690	$5.76M	0.0%	+1.4%	0.167%
9/21/2023	Barclays PLC	131,342	$4.18M	0.0%	-78.1%	0.083%
8/24/2023	Perceptive Advisors LLC	10,088,385	$320.71M	9.3%	+54.9%	6.406%
8/21/2023	Affinity Asset Advisors LLC	550,000	$17.48M	6.0%	+44.7%	0.349%
8/14/2023	NinePointTwo Capital LLC	8,151	$0.26M	0.1%	N/A	0.005%
8/14/2023	Jefferies Financial Group Inc.	25,000	$0.80M	0.0%	-50.0%	0.016%
8/14/2023	UniSuper Management Pty Ltd	97,429	$3.10M	0.0%	N/A	0.062%
8/14/2023	Polar Capital Holdings Plc	910,762	$28.95M	0.2%	+18.5%	0.578%
8/14/2023	Graham Capital Management L.P.	10,344	$0.33M	0.0%	N/A	0.007%
8/11/2023	The Manufacturers Life Insurance Company	146,096	$4.64M	0.0%	+14.7%	0.093%
8/11/2023	Artal Group S.A.	1,638,858	$52.10M	1.6%	-14.4%	1.045%
8/11/2023	E Fund Management Co. Ltd.	9,501	$0.30M	0.0%	-20.4%	0.006%
8/11/2023	ExodusPoint Capital Management LP	15,245	$0.49M	0.0%	N/A	0.010%
8/10/2023	MetLife Investment Management LLC	32,786	$1.04M	0.0%	+7.8%	0.021%
8/10/2023	ProShare Advisors LLC	8,048	$0.26M	0.0%	N/A	0.005%
8/10/2023	Profund Advisors LLC	32,605	$1.04M	0.1%	-17.1%	0.021%

Data available starting January 2016

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $42.14

$41.80

$42.19

50 Day Range

MA: $41.87

$40.88

$42.93

52 Week Range

Now: $42.14

$19.59

$43.59

Volume

351,935 shs

Average Volume

1,476,965 shs

Market Capitalization

$7.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

Who are the company insiders with the largest holdings of Cerevel Therapeutics?: Cerevel Therapeutics' top insider investors include:
Bain Capital Investors Llc (Major Shareholder)
Perceptive Advisors Llc (Director)
Marijn E Dekkers (Director)
Ronald C Renaud Jr (CEO)
Kenneth Dipietro (Insider)
Paul D Burgess (Insider)
Mark Bodenrader (Insider)
Susan Altschuller (CFO)
N Anthony Coles (Director)
Ramiro Sanchez (Insider)
John Renger (Insider)
N Anthony Coles (CEO)
Scott Akamine (Insider)
Abraham Ceesay (President)
Deval L Patrick (Director)
Learn More about top insider investors at Cerevel Therapeutics.
Who are the major institutional investors of Cerevel Therapeutics?: Cerevel Therapeutics' top institutional shareholders include:
Simplex Trading LLC — 0.00%
Learn More about top institutional investors of Cerevel Therapeutics stock.
Which major investors are buying Cerevel Therapeutics stock?: During the previous quarter, CERE stock was acquired by institutional investors including:
Simplex Trading LLC
Within the previous year, these company insiders have bought Cerevel Therapeutics stock:
Bain Capital Investors Llc (Major Shareholder)
Perceptive Advisors Llc (Director)
Marijn E Dekkers (Director)
Ronald C Renaud Jr (CEO)
Learn More investors buying Cerevel Therapeutics stock.